141 related articles for article (PubMed ID: 37394642)
1. Decreased Analgesic Effect of Tramadol in Japanese Patients with CYP2D6 Intermediate Metabolizers after Orthopedic Surgery.
Kamiya T; Hira D; Nakajima R; Shinoda K; Motomochi A; Morikochi A; Ikeda Y; Isono T; Akabane M; Ueshima S; Kakumoto M; Imai S; Morita SY; Terada T
Biol Pharm Bull; 2023; 46(7):907-913. PubMed ID: 37394642
[TBL] [Abstract][Full Text] [Related]
2. CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients.
Nasare NV; Banerjee BD; Suryakantrao Deshmukh P; Mediratta PK; Saxena AK; Ahmed RS; Bhattacharya SN
Am J Ther; 2016; 23(3):e697-707. PubMed ID: 23567787
[TBL] [Abstract][Full Text] [Related]
3. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
Gan SH; Ismail R; Wan Adnan WA; Zulmi W
Mol Diagn Ther; 2007; 11(3):171-81. PubMed ID: 17570739
[TBL] [Abstract][Full Text] [Related]
4. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2D6 genotype on postoperative tramadol analgesia.
Stamer UM; Lehnen K; Höthker F; Bayerer B; Wolf S; Hoeft A; Stuber F
Pain; 2003 Sep; 105(1-2):231-8. PubMed ID: 14499440
[TBL] [Abstract][Full Text] [Related]
7. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.
Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH
Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496
[TBL] [Abstract][Full Text] [Related]
8. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
[TBL] [Abstract][Full Text] [Related]
9. Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.
Dong H; Lu SJ; Zhang R; Liu DD; Zhang YZ; Song CY
Eur J Clin Pharmacol; 2015 Jun; 71(6):681-686. PubMed ID: 25948472
[TBL] [Abstract][Full Text] [Related]
10. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
Zahari Z; Ismail R
Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
[TBL] [Abstract][Full Text] [Related]
11. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
12. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.
Orliaguet G; Hamza J; Couloigner V; Denoyelle F; Loriot MA; Broly F; Garabedian EN
Pediatrics; 2015 Mar; 135(3):e753-5. PubMed ID: 25647677
[TBL] [Abstract][Full Text] [Related]
13. Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.
Wang G; Zhang H; He F; Fang X
Eur J Clin Pharmacol; 2006 Nov; 62(11):927-31. PubMed ID: 16960721
[TBL] [Abstract][Full Text] [Related]
14. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.
Enggaard TP; Poulsen L; Arendt-Nielsen L; Brøsen K; Ossig J; Sindrup SH
Anesth Analg; 2006 Jan; 102(1):146-50. PubMed ID: 16368820
[TBL] [Abstract][Full Text] [Related]
15. Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.
Slanar O; Dupal P; Matouskova O; Vondrackova H; Pafko P; Perlik F
Bratisl Lek Listy; 2012; 113(3):152-5. PubMed ID: 22428763
[TBL] [Abstract][Full Text] [Related]
16. Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.
Seripa D; Latina P; Fontana A; Gravina C; Lattanzi M; Savino M; Gallo AP; Melchionda G; Santini SA; Margaglione M; Copetti M; di Mauro L; Panza F; Greco A; Pilotto A
Pain Med; 2015 Oct; 16(10):2012-23. PubMed ID: 25989235
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6 Basic Genotyping of Patients with Chronic Pain Receiving Tramadol or Codeine. A Study in a Greek Cohort.
Batistaki C; Chrona E; Kostroglou A; Kostopanagiotou G; Gazouli M
Pain Med; 2020 Nov; 21(11):3199-3204. PubMed ID: 32443139
[TBL] [Abstract][Full Text] [Related]
18. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).
Matic M; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GAPJM; Weide JV; Wilffert B; Swen JJ; Guchelaar HJ; Deneer VHM; van Schaik RHN
Eur J Hum Genet; 2022 Oct; 30(10):1105-1113. PubMed ID: 34267337
[TBL] [Abstract][Full Text] [Related]
19. Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.
Elkalioubie A; Allorge D; Robriquet L; Wiart JF; Garat A; Broly F; Fourrier F
Eur J Clin Pharmacol; 2011 Aug; 67(8):855-8. PubMed ID: 21691803
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
